Association of the Metabolic Syndrome with History of Myocardial Infarction and Stroke in the Third National Health and Nutrition Examination Survey

Circulation

Volumn 109, Issue 1, 2004, Pages 42-46

  Ninomiya, John K ^a   L'Italien, Gilbert ^b   Criqui, Michael H ^a   Whyte, Joanna L ^c   Gamst, Anthony ^a   Chen, Roland S ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Ingenix Inc   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

Epidemiology; Myocardial infarction; Risk factors; Stroke; Syndrome X

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; HEALTH SURVEY; HEART INFARCTION; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORBIDITY; OBESITY; PREVALENCE; PRIORITY JOURNAL; STROKE;

ADULT; AGED; AGED, 80 AND OVER; BODY SIZE; CEREBROVASCULAR ACCIDENT; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MYOCARDIAL INFARCTION; NUTRITION SURVEYS; ODDS RATIO; PREVALENCE; UNITED STATES;

EID: 0347716449     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000108926.04022.0C     Document Type: Article

References (19)

1. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
2. Deedwania PC. The deadly quartet revisited. Am J Med. 1998;105(suppl 1A):1S-3S.
3. Alberi KGMM, Zimmet PZ, for the WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications, part I: diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabet Med. 1998;15:539-553.
4. Groop L, Orho-Melander M. The dysmetabolic syndrome. J Int Med. 2001;250:105-120.
5. Fagan TC, Deedwania PC. The cardiovascular dysmetabolic syndrome. Am J Med. 1998;105(suppl 1A):77S-82S.
6. Deleted in proof.
7. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel 111). JAMA. 2001;285:2486-2497.
8. National Center for Health Statistics. Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988-1994. Hyattsville, Md: National Center for Health Statistics; 1995.
9. Qureshi AI, Giles WH, Croft JB. Impaired glucose tolerance and the likelihood of nonfatal stroke and myocardial infarction: the Third National Health and Nutrition Examination Survey. Stroke. 1998;29: 1329-1332.
10. Shah BV, Barnwell BG, Bieler GS. SUDAAN User's Manual. Version 7.5. Research Triangle Park, NC: Research Triangle Institute; 1997.
11. Daly P, Solomon C, Manson J. Risk modification in the obese patient. In: Manson J, Ridker P, Gaziano J, et al, eds. Prevention of Myocardial Infarction. New York: Oxford University Press; 1996:203-240.
12. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol: a meta-analysis population-based prospective studies. J Cardiovasc Risk. 1996;3:213-219.
13. Ford ES, Giles WH, Croft JB. Prevalence of nonfatal coronary disease among American adults. Am Heart J. 2000;139:371-377.
14. Colditz GA, Martin P, Stampfer MJ, et al. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol. 1986;123:894-900.
15. Psaty BM, Kuller LH, Bild D, et al. Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. Ann Epidemiol. 1995;5:270-277.
16. Rosamond WD, Sprafka JM, McGovern PG, et al. Validation of self-reported history of acute myocardial infarction: experience of the Minnesota Heart Survey Registry. Epidemiology. 1995;6:67-69.
17. Rothman KJ, Greenland S. Types of epidemiologic studies. In: Rothman KJ, Greenland S, eds. Modern Epidemiology. Philadelphia: Raven-Lippincott Publishers: 1998:75.
18. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709-2716.
19. McNeill AM, Rosamond WD, Girman CJ, et al. A new definition of the metabolic syndrome predicts incident coronary heart disease and ischemic stroke. Circulation. 2002;106(suppl II):II-765. Abstract.